Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells.

PubWeight™: 1.89‹?› | Rank: Top 3%

🔗 View Article (PMID 8149966)

Published in Eur J Immunol on April 01, 1994

Authors

A W Taylor-Robinson1, F Y Liew, A Severn, D Xu, S J McSorley, P Garside, J Padron, R S Phillips

Author Affiliations

1: Wellcome Laboratory for Experimental Parasitology, University of Glasgow.

Articles citing this

Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev (2010) 3.31

Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med (1994) 2.46

Role of nitric oxide in parasitic infections. Microbiol Rev (1995) 1.91

Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun (1998) 1.89

Nitric oxide and virus infection. Immunology (2000) 1.78

Multiple roles of nitric oxide in the airways. Thorax (2003) 1.69

A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology (1994) 1.54

Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice. Infect Immun (2006) 1.45

Oxidative stress in malaria. Int J Mol Sci (2012) 1.24

T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase. J Clin Invest (2004) 1.17

Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol (2002) 1.15

Mechanisms of virus induced exacerbations of asthma. Thorax (1997) 1.12

Nitric oxide and thiol redox regulation of Janus kinase activity. Proc Natl Acad Sci U S A (1998) 1.11

The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J Exp Med (1994) 1.10

S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol (2010) 1.09

Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice. Respir Res (2006) 1.07

Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology (1997) 1.05

T-Cell hyporesponsiveness induced by activated macrophages through nitric oxide production in mice infected with Mycobacterium tuberculosis. Infect Immun (1999) 1.05

Inhibition of influenza virus replication by nitric oxide. J Virol (1999) 1.04

In vitro simulation of immunosuppression caused by Trypanosoma brucei: active involvement of gamma interferon and tumor necrosis factor in the pathway of suppression. Infect Immun (1996) 1.03

Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology (1997) 1.02

Mechanisms of hepatic ischemia-reperfusion injury and protective effects of nitric oxide. World J Gastrointest Surg (2014) 1.02

Activation of CFTR chloride current by nitric oxide in human T lymphocytes. EMBO J (1995) 1.00

Effect of late modulation of nitric oxide production on murine lupus. Clin Immunol Immunopathol (1997) 0.99

CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection. J Immunol (2010) 0.99

Nitric oxide increased interleukin-4 expression in T lymphocytes. Immunology (1997) 0.98

Nitric oxide-enhanced resistance to oral candidiasis. Immunology (2001) 0.97

Disruption of fas receptor signaling by nitric oxide in eosinophils. J Exp Med (1998) 0.93

Central role for interleukin-4 in regulating nitric oxide-mediated inhibition of T-cell proliferation and gamma interferon production in schistosomiasis. Infect Immun (2002) 0.93

Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J Virol (2005) 0.92

Attenuated Salmonella vaccine-induced suppression of murine spleen cell responses to mitogen is mediated by macrophage nitric oxide: quantitative aspects. Infect Immun (1996) 0.92

Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria. Clin Exp Immunol (2000) 0.91

Babesia bovis rhoptry-associated protein 1 is immunodominant for T helper cells of immune cattle and contains T-cell epitopes conserved among geographically distant B. bovis strains. Infect Immun (1996) 0.91

Nitric oxide and cGMP protein kinase (cGK) regulate dendritic-cell migration toward the lymph-node-directing chemokine CCL19. Blood (2005) 0.90

Immunoregulatory and antimicrobial effects of nitrogen oxides. Proc Am Thorac Soc (2006) 0.89

Immunomodulatory properties of porins of some members of the family Enterobacteriaceae. Infect Immun (1997) 0.89

The role of nitric oxide in experimental murine sepsis due to pyrogenic exotoxin A-producing Streptococcus pyogenes. Infect Immun (1997) 0.88

Cytokine regulation on the synthesis of nitric oxide in vivo by chronically infected human polymorphonuclear leucocytes. Immunology (1998) 0.85

Exhaled nitric oxide in sarcoidosis. Thorax (2005) 0.82

The complex role of iNOS in acutely rejecting cardiac transplants. Free Radic Biol Med (2008) 0.80

Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat. J Clin Invest (1997) 0.80

Inhibition of nitric oxide interrupts the accumulation of CD8+ T cells surrounding Plasmodium berghei-infected hepatocytes. Infect Immun (1997) 0.80

Cell-specific effects of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA expression. Immunology (1997) 0.79

Inhibitory activity of constitutive nitric oxide on the expression of alpha/beta interferon genes in murine peritoneal macrophages. J Virol (1999) 0.79

Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats. Clin Exp Immunol (2001) 0.79

Alveolar macrophages of allergic resistant and susceptible strains of rats show distinct cytokine profiles. Clin Exp Immunol (2001) 0.78

Role of Arginine and Omega-3 Fatty Acids in Wound Healing and Infection. Adv Wound Care (New Rochelle) (2014) 0.78

A Dirofilaria immitis polyprotein up-regulates nitric oxide production. Infect Immun (2002) 0.78

Heroin-induced conditioned immunomodulation requires expression of IL-1β in the dorsal hippocampus. Brain Behav Immun (2013) 0.78

Staphylococcal enterotoxin A acts through nitric oxide synthase mechanisms in human peripheral blood mononuclear cells to stimulate synthesis of pyrogenic cytokines. Infect Immun (2000) 0.78

Nitric oxide regulates clonal expansion and activation-induced cell death triggered by staphylococcal enterotoxin B. Infect Immun (1997) 0.78

Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation. J Immunol Res (2016) 0.76

Nitric oxide modulates interleukin-2-induced proliferation in CTLL-2 cells. Mediators Inflamm (1996) 0.75

Plasma nitrate plus nitrite changes during continuous intravenous infusion interleukin 2. Br J Cancer (1996) 0.75

NADPH diaphorase-positive dendritic profiles in rat thymus are discrete from autofluorescent cells, immunoreactive for inducible nitric oxide synthase, and show strain-specific abundance differences. Immunology (1998) 0.75

Role of nitric oxide in developmental biology in plants, bacteria, and man. Curr Top Pharmacol (2011) 0.75

Comparative study of nitric oxide (NO) production during human hydatidosis: relationship with cystic fluid fertility. Parasitol Res (2012) 0.75

Articles by these authors

Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA (1998) 12.60

Effect of computer-based alerts on the treatment and outcomes of hospitalized patients. Arch Intern Med (1994) 8.20

Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med (1997) 6.55

Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (1995) 6.20

Climate change. Recent reductions in China's greenhouse gas emissions. Science (2001) 5.77

Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol (1999) 5.55

Voxel-based morphometry using the RAVENS maps: methods and validation using simulated longitudinal atrophy. Neuroimage (2001) 4.58

Patient preferences for communication with physicians about end-of-life decisions. SUPPORT Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatment. Ann Intern Med (1997) 4.56

Do formal advance directives affect resuscitation decisions and the use of resources for seriously ill patients? SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Clin Ethics (1994) 4.23

Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med (1997) 4.03

Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med (2001) 3.97

In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol (2001) 3.65

Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell (1999) 3.58

Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med (1998) 3.53

Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann Intern Med (2000) 3.49

Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized Elderly Longitudinal Project. JAMA (1998) 3.47

Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice. Infect Immun (1988) 3.44

Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol (2004) 3.37

Do advance directives provide instructions that direct care? SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc (1997) 3.37

Synaptic clustering of AMPA receptors by the extracellular immediate-early gene product Narp. Neuron (1999) 3.28

Use of administrative data to find substandard care: validation of the complications screening program. Med Care (2000) 3.26

The impact of serious illness on patients' families. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. JAMA (1994) 3.14

Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Circulation (1998) 3.11

An extremely luminous panchromatic outburst from the nucleus of a distant galaxy. Science (2011) 3.09

The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med (1995) 3.08

Development of the 'Activities of Daily Vision Scale'. A measure of visual functional status. Med Care (1992) 3.06

The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med (1996) 2.99

Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica. J Exp Med (1980) 2.97

Resource use and survival of patients hospitalized with congestive heart failure: differences in care by specialty of the attending physician. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med (2000) 2.96

Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med (1998) 2.85

Physician counseling about exercise. JAMA (1999) 2.85

Advance directives for seriously ill hospitalized patients: effectiveness with the patient self-determination act and the SUPPORT intervention. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc (1997) 2.84

A comparative study of contrast agents for endoscopic retrograde pancreatography. Am J Gastroenterol (1991) 2.75

Does clinical evidence support ICD-9-CM diagnosis coding of complications? Med Care (2000) 2.74

A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest (1999) 2.65

Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur J Immunol (1984) 2.57

Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica. J Exp Med (1981) 2.50

Post-hemorrhagic shock mesenteric lymph is cytotoxic to endothelial cells and activates neutrophils. Shock (1998) 2.48

Use of a direct fluorescent antibody test for detecting Chlamydia trachomatis cervical infection in women seeking routine gynecologic care. J Infect Dis (1987) 2.40

Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med (1998) 2.40

The role of TH1 and TH2 cells in a rodent malaria infection. Science (1993) 2.38

Older age, aggressiveness of care, and survival for seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med (1999) 2.34

Alternative medicine use in older Americans. J Am Geriatr Soc (2000) 2.32

Protein threading using PROSPECT: design and evaluation. Proteins (2000) 2.26

The effect of computer-based reminders on the management of hospitalized patients with worsening renal function. Proc Annu Symp Comput Appl Med Care (1991) 2.22

Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells. J Immunol (1982) 2.21

A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur J Immunol (1991) 2.15

Health values of the seriously ill. SUPPORT investigators. Ann Intern Med (1995) 2.14

Communication and decision-making in seriously ill patients: findings of the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc (2000) 2.12

Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc (2000) 2.09

Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun (1992) 2.08

Pain and satisfaction with pain control in seriously ill hospitalized adults: findings from the SUPPORT research investigations. For the SUPPORT investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatmentm. Crit Care Med (1996) 2.06

Patients discharged against medical advice from a general medicine service. J Gen Intern Med (1998) 2.04

Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells. J Biol Chem (1996) 2.02

Nitric oxide and asthmatic inflammation. Immunol Today (1995) 2.01

Patient-physician communication at hospital discharge and patients' understanding of the postdischarge treatment plan. Arch Intern Med (1997) 2.00

MR imaging, MR spectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am J Neuroradiol (2006) 2.00

Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J Immunol (1999) 2.00

Indole can act as an extracellular signal to regulate biofilm formation of Escherichia coli and other indole-producing bacteria. Can J Microbiol (2003) 1.98

Evidence based mergers? BMJ (1999) 1.98

Functional heterogeneity of CD4+ T cells in leishmaniasis. Immunol Today (1989) 1.97

Regulation of delayed-type hypersensitivity. I. T suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice. Eur J Immunol (1977) 1.94

Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems. Microb Pathog (1987) 1.93

Improved visual function and attenuation of declines in health-related quality of life after cataract extraction. Arch Ophthalmol (1994) 1.93

Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis. Immunology (1990) 1.91

A new set of chemotaxis homologues is essential for Myxococcus xanthus social motility. Mol Microbiol (1998) 1.91

Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J Immunol (1990) 1.90

Immune response to chemically modified flagellin. 3. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J Exp Med (1972) 1.90

Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice. Eur J Immunol (1978) 1.89

Relationship of body mass index to subsequent mortality among seriously ill hospitalized patients. SUPPORT Investigators. The Study to Understand Prognoses and Preferences for Outcome and Risks of Treatments. Crit Care Med (1997) 1.89

Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection. J Immunol (1982) 1.89

Immunity to malaria. II. Serological response of monkeys sensitized by drug-suppressed infection or by dead parasitized cells in Freund's complete adjuvant. Exp Parasitol (1970) 1.86

Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med (1996) 1.85

The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin. J Biol Chem (1998) 1.83

Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol (1992) 1.83

T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin. Nature (1979) 1.82

Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol (1994) 1.82

The last six months of life for patients with congestive heart failure. J Am Geriatr Soc (2000) 1.82

A giant outburst two years before the core-collapse of a massive star. Nature (2007) 1.82

Patient age and decisions to withhold life-sustaining treatments from seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Ann Intern Med (1999) 1.81

Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol (1998) 1.81

Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH. J Immunol (1984) 1.81

Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. J Immunol (2000) 1.80

Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci U S A (1999) 1.80

Interorganellar communication. Altered nuclear gene expression profiles in a yeast mitochondrial dna mutant. J Biol Chem (2000) 1.80

Insecticidal proteins from Bacillus thuringiensis protect corn from corn rootworms. Nat Biotechnol (2001) 1.80

Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med (1995) 1.80

Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol (1993) 1.79

Method to test inhibitory antibodies in human sera to wild populations of Plasmodium falciparum. Nature (1976) 1.79

A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol (2001) 1.78

Automated vocal analysis of naturalistic recordings from children with autism, language delay, and typical development. Proc Natl Acad Sci U S A (2010) 1.78

Outcomes, preferences for resuscitation, and physician-patient communication among patients with metastatic colorectal cancer. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Am J Med (1998) 1.78

Histopathology and fibrillin-1 distribution in severe early onset Marfan syndrome. Am J Med Genet A (2005) 1.77